2.
诱导治疗组和直接手术组临床病理特征(剔除Masaoka-Koga Ⅳ期病例)
Patients' characteristics of Masaoka-Koga stage Ⅲ in the DS group and those of pathological Masaoka-Koga stage Ⅰ-Ⅲ in the IT group
| Variables | IT(n=55) | DS(n=499) | P value |
| IT: Induction therapies; DS: Directly surgery; C: Carcinoma; NETT: Neuroendocrine thymic tumor. 注：本表得到版权所有者©2011-2016 Journal of Thoracic Disease复制许可。 | |||
| Gender | 0.941 | ||
| Male | 34(61.8%) | 311(62.3%) | |
| Female | 21(38.2%) | 188(37.7%) | |
| Age(yr, mean±SD) | 45.3±14.7 | 51.6±13 | 0.135 |
| Tumor size(cm, mean±SD) | 7.96±2.7 | 7.92±3.2 | 0.224 |
| Preoperative MG | 0.000 | ||
| No | 50(90.9%) | 379(76%) | |
| Yes | 5(9.1%) | 120(24%) | |
| WHO histological types | 0.332 | ||
| A | 2(3.6%) | 10(2%) | |
| AB | 5(9.1%) | 40(8%) | |
| B1 | 4(7.3%) | 40(8%) | |
| B2 | 4(7.3%) | 40(8%) | |
| B3 | 11(20%) | 140(28.1%) | |
| C | 28(50.9%) | 183(36.7%) | |
| NETT | 1(1.8%) | 16(3.2%) | |
| WHO histological types(combination) | 0.022 | ||
| Thymoma | 26(47.3%) | 300(60.1%) | |
| C+NETT | 29(52.7%) | 199(39.9%) | |
| Resection State | 0.63 | ||
| R0 | 42(76.4%) | 366(73.3%) | |
| R1+R2 | 13(23.6%) | 133(26.7%) | |